LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
TPSTCIK 0001544227

Tempest Therapeutics, Inc.

14 transactions by 10 insiders, from January 27, 2026 to September 22, 2026.

Transactions
1410 insiders
Bought · P
$1.0Mopen market
Sold · S
Nonenobody sold on the open market
Net
+$1.0Mnet buying

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
Matthew AngelCEO5—$1.0M—
Geoffrey NicholDir1———
Michael RaabDir1———
Nicholas MaestasCFO1———
Ronit SimantovDir1———
John D. YeeDir1———
Justin TrojanowskiCAO1———
Nancy Freda SmithDir1———
Christine A. PellizzariDir1———
William Drake RicheyDir1———

All transactions

14 in total, newest filings first.

InsiderDateCodeSharesPriceValue
Nancy Freda SmithDirDERIVSep 22A25,000$0.00—?
Matthew AngelCEODERIVMar 24P231,482——
Matthew AngelCEODERIVMar 24P231,482——
Matthew AngelCEOMar 24P231,482$2.16$500K
John D. YeeDirDERIVJun 4A25,000$0.00—?
William Drake RicheyDirDERIVJun 4A25,000$0.00—?
Justin TrojanowskiCAODERIVMar 31A22,000$0.00—?
Nicholas MaestasCFODERIVMar 31A140,000$0.00—?
Matthew AngelCEOMar 24P231,482$2.16$500K
Matthew AngelCEODERIVFeb 4A269,621$0.00—?
Ronit SimantovDirDERIVJan 27A1,230$0.00—?
Michael RaabDirDERIVJan 27A1,230$0.00—?
Christine A. PellizzariDirDERIVJan 27A1,230$0.00—?
Geoffrey NicholDirDERIVJan 27A1,230$0.00—?